Navigation Links
Anti-Cancer Drug Restores Normal Cell Growth

An experimental anti-cancer drug has shown effectiveness in treating a resistant type of lymphoma, according to a new report. Researchers say the drug probably acts on many types of cancer cells, so it may be useful for treating other types of cancer. Dr. Antonio Fojo of the National Cancer Institute in Bethesda, Maryland, and colleagues tested the drug, depsipeptide//, in patients with T-cell lymphoma, a cancer of the lymphatic system that rarely responds to chemotherapy.

Depsipeptide is a member of a class of drugs known as histone deacetylase inhibitors. Fojo and colleagues believe these drugs may help restore normal growth to cancer cells, which typically arise from normal cells in which growth regulation has gone awry.

The drug's side effects were comparable to those seen with other types of chemotherapy and included fatigue, nausea and vomiting, lowered platelet count and abnormal heart rhythm, the researchers add. "These results suggest that is a novel and potentially effective therapy for patients with T-cell lymphoma," Fojo's team concludes.


'"/>




Page: 1

Related medicine news :

1. FDA Approves Anti-Cancer Cell Drug - Zevalin
2. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
3. Premature Aging Can Be Managed With Anti-Cancer Drugs In Future
4. Antidepressant Drug Found To Have Anti-Cancer Effects
5. Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes
6. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
7. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
8. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
9. Exercise Has An Anti-Cancer Effect
10. A New Anti-Cancer Drug Keeps Resistance Out
11. A New Approach towards Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 05, 2018 , ... ... engagement with the use of the Precision Virtual Reality® medical visualization platform ... world-renowned neurosurgeons and physicians with a never-before view of the anatomy and ...
(Date:12/5/2018)... ... 2018 , ... Since PermaLip™ implants are solid, patients do not ... naked eye, ensuring a natural look. “I always double and triple check implant placement ... implant visibility,” says Dr. Jessica Kulak, double board certified facial plastic surgeon at The ...
(Date:12/5/2018)... ... 2018 , ... You can now experience two cutting edge Oregon brands at ... powerhouse in the cannabis industry with several brands including Sticks and ... award winning , botanical terpene company that focuses on using terpenes from non-cannabis ...
(Date:11/29/2018)... ... November 29, 2018 , ... ... today, “ Investing in the Future: Why Preventing Chronic Disease is Essential - ... chronic disease prevention, control, and health promotion. , The paper outlines some ...
(Date:11/28/2018)... ... 28, 2018 , ... Melania Trump, first lady of the United States, took ... event addressing the national opioid epidemic. The event was filmed for the pilot episode ... to an accidental opioid overdose last year. The program is scheduled to air nationally ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... ... December 05, 2018 , ... WHO: The Institute for Healthcare Improvement ... of four keynote addresses and five spotlight sessions taking place during the 30th annual ... and speakers) , WHEN: Beginning Tuesday, December 11 ( full schedule ) , ...
(Date:12/5/2018)... ... December 05, 2018 , ... Medical Device Cybersecurity ... FDAnews Webinar**, Tuesday, Dec. 18, 2018, 1:30 p.m. - 3:00 p.m. ET, ... become. , Cybersecurity is becoming an everyday risk. , FDAnews has reached ...
(Date:12/5/2018)... ... 05, 2018 , ... Smart pill device and app developer ... today announced the launch of its new user-oriented nutritional supplement subscription service ... its pioneering technology to enhance users’ control of, and adherence to, nutritional supplement ...
Breaking Medicine Technology: